Cargando…

Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are fatal diseases; however, their pathogenesis still remains to be elucidated. We have recently screened novel pathogenic molecules and have performed drug discovery targeting those molecules. Pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satoh, Kimio, Kikuchi, Nobuhiro, Satoh, Taijyu, Kurosawa, Ryo, Sunamura, Shinichiro, Siddique, Mohammad Abdul Hai, Omura, Junichi, Yaoita, Nobuhiro, Shimokawa, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321293/ https://www.ncbi.nlm.nih.gov/pubmed/30562953 http://dx.doi.org/10.3390/ijms19124081

Ejemplares similares

Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease
por: Ohtsuki, Tomohiro, et al.
Publicado: (2019)

Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Yaoita, Nobuhiro, et al.
Publicado: (2020)

Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension
por: Kozu, Katsuya, et al.
Publicado: (2018)

Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left‐sided heart diseases
por: Satoh, Taijyu, et al.
Publicado: (2023)

The Efficacy of a Genetic Analysis of the BMPR2 Gene in a Patient with Severe Pulmonary Arterial Hypertension and an Atrial Septal Defect Treated with Bilateral Lung Transplantation
por: Tatebe, Shunsuke, et al.
Publicado: (2017)

4D-flow MRI assessment of blood flow before and after endovascular intervention in a patient with pulmonary hypertension due to isolated pulmonary artery involvement in large vessel vasculitis
por: Kamada, Hiroki, et al.
Publicado: (2019)

Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty – A randomized controlled study
por: Aoki, Tatsuo, et al.
Publicado: (2020)

Successful Management of Acute Congestive Heart Failure by Emergent Caesarean Section Followed by Adrenalectomy in a Pregnant Woman with Cushing's Syndrome-induced Cardiomyopathy
por: Sakota, Miku, et al.
Publicado: (2019)

Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR)
por: Tamura, Yuichi, et al.
Publicado: (2021)

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension
por: Furuya, Yoshiaki, et al.
Publicado: (2010)

Novel diagnostic and therapeutic approaches to pulmonary hypertension due to the unilateral absence of a pulmonary artery
por: Nagamatsu, Yuki, et al.
Publicado: (2021)

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
por: Sakao, Seiichiro, et al.
Publicado: (2015)

Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension
por: Rabieyousefi, Moloud, et al.
Publicado: (2011)

Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension　― Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers ―
por: Ishiguro, Midori, et al.
Publicado: (2020)

Racemose Hemangioma of the Bronchial Artery
por: Osawa, Hajime, et al.
Publicado: (2017)

Arterial methemoglobin level predicts therapeutic effectiveness of the PDE5 inhibitors in patients with in idiopathic pulmonary arterial hypertension
por: Tamura, Yuichi, et al.
Publicado: (2011)

Pulmonary artery pressure–perfusion relation during exercise in patients with chronic thromboembolic pulmonary hypertension using pulmonary arteriography and right-heart catheterization
por: Goda, Ayumi, et al.
Publicado: (2023)

Re: Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and clinical significance
por: Okauchi, Shinichiro, et al.
Publicado: (2022)

A Leadless Pacemaker Which Became Encapsulated Only Two Months after Placement
por: Satoh, Taijyu, et al.
Publicado: (2018)

Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
por: Tobita, Kazuki, et al.
Publicado: (2023)

Reversible Cardiac Hypertrophy in Pulmonary Arterial Hypertension Treated With High-Dose Epoprostenol
por: Izumi, Keiichi, et al.
Publicado: (2022)

Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension
por: Chibana, Hidetoshi, et al.
Publicado: (2017)

Heritable pulmonary arterial hypertension complicated by multiple pulmonary arteriovenous malformations
por: Arano, Takahiro, et al.
Publicado: (2021)

Computational repurposing of therapeutic small molecules from cancer to pulmonary hypertension
por: Negi, Vinny, et al.
Publicado: (2021)

Successful Management and Risk Stratification by Exercise Right Heart Catheterization Before Pregnancy in a Patient With Pulmonary Arterial Hypertension
por: Yanagisawa, Yoshiaki, et al.
Publicado: (2023)

Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation
por: Yamamoto, Saori, et al.
Publicado: (2018)

Real‐world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database
por: Omura, Junichi, et al.
Publicado: (2023)

Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis
por: Sakao, Seiichiro, et al.
Publicado: (2019)

Combination Therapy with Atorvastatin and Amlodipine Suppresses Angiotensin II-Induced Aortic Aneurysm Formation
por: Takahashi, Kikuyo, et al.
Publicado: (2013)

Psychometric Validation of a Japanese Version of the emPHasis-10 Questionnaire, a Patient-Reported Outcome Measure for Pulmonary Hypertension　― Multicenter Study in Japan ―
por: Takeyasu, Rika, et al.
Publicado: (2020)

Combination Therapy With Pulmonary Vasodilatation and JAK2 Inhibition for Pulmonary Hypertension With Polycythemia Vera
por: Momose, Riichi, et al.
Publicado: (2022)

Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
por: Tamura, Yuichi, et al.
Publicado: (2013)

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2017)

Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody
por: Ishii, Yusho, et al.
Publicado: (2020)

A New Era of Therapeutic Strategies for Chronic Thromboembolic Pulmonary Hypertension by Two Different Interventional Therapies; Pulmonary Endarterectomy and Percutaneous Transluminal Pulmonary Angioplasty
por: Inami, Takumi, et al.
Publicado: (2014)

Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension
por: Tanaka, Hiroaki, et al.
Publicado: (2017)

Immunosuppressive therapy ameliorates refractory vasospastic angina, severe pulmonary hypertension, and bronchiolitis in a patient with eosinophilic granulomatosis with polyangiitis: a case report
por: Konno, Ryo, et al.
Publicado: (2018)

Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance
por: Jujo, Takayuki, et al.
Publicado: (2015)

Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
por: Tamura, Yuichi, et al.
Publicado: (2013)

Isolation and Characterization of Basidiomycetous Yeasts Capable of Producing Phytase under Oligotrophic Conditions
por: Kurosawa, Akino, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jaiek4odo3g38d420l942c971m